The San Francisco firm previously raised $30 million for its debut in 2018. That inaugural fund has already notched one exit, the sale of Intabio to SCIEX in 2021, which has allowed the firm to return half of its invested capital to LPs, said Jenny Rooke, Genoa’s founder and managing director.
Read the full article on Venture Capital Journal HERE.